Clinical trial
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
NCT00842673
Study timeline
Study start (unknown)2009-02-01Date precision: month
Registry last updated2012-06-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
Sponsors & collaborators
Sonexa Therapeutics, Inc.lead sponsor
Mapped research locations
TorontoOntario, Canada1San DiegoCalifornia, United States1MontrealQuebec, Canada1DurhamNorth Carolina, United States1IndianapolisIndiana, United States1OrlandoFlorida, United States1West Palm BeachFlorida, United States1ToledoOhio, United States1Walnut CreekCalifornia, United States1ShreveportLouisiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00842673 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.